Table 3.
Variable | Breast cancer | Cervical cancer | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cases | Deaths | 5-y OS | pa | HR (95% CI) | Cases | Deaths | 5-y OS | pa | HR (95% CI) | |
Overall survival | 2110 | 597 | 74.3 | – | – | 978 | 200 | 70.7 | – | – |
Year of Diagnoses | ||||||||||
2000–2004 | 410 | 204 | 67.1 | 0.058 | Reference | 249 | 90 | 68.3 | 0.004 | Reference |
2005–2009 | 596 | 194 | 77.5 | 0.797 (0.648; 0.980) | 185 | 51 | 64.2 | 1.214 (0.848; 1.739) | ||
2010–2015 | 1104 | 199 | 75.0 | 0.801 (0.645; 0.996) | 551 | 59 | 73.4 | 0.652 (0.456; 0.932) | ||
Clinical stage of disease at Diagnosis (Breast cancer: TNM; Cervical Cancer: FIGO) | ||||||||||
In situ | 338 | 26 | 96.0 | < 0.001 | 0.035 (0.023; 0.053) | 619 | 26 | 93.6 | < 0.001 | 0.023 (0.014; 0.038) |
I | 468 | 61 | 89.4 | 0.061 (0.045; 0.082) | 84 | 14 | 87.3 | 0.051 (0.027; 0.095) | ||
II | 649 | 154 | 81.9 | 0.097 (0.077; 0.121) | 91 | 29 | 61.0 | 0.133 (0.082; 0.216) | ||
III | 405 | 184 | 57.3 | 0.269 (0.216; 0.334) | 94 | 63 | 34.3 | 0.362 (0.245; 0.536) | ||
IV | 183 | 154 | 12.3 | Reference | 51 | 46 | 5.1 | Reference |
aKaplan-Meier; HR hazard ratio, CI confidence interval. 5-y OS, 5-year overall survival